Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: J Immunol. 2018 May 14;201(1):134–144. doi: 10.4049/jimmunol.1701406

Figure 3.

Figure 3

AMs are reduced in C57Bl/6 mice following i.n., but not i.v., administration of clodronate liposomes. (A) Naïve and CA04 infected mice were treated with clodronate- or PBS-containing liposomes by i.n. or i.v. injection on days 7 and 8 post-influenza infection. Representative dot plots show the gating strategy for AMs and CD11cloMCs in the BAL of naïve and CA04-infected C57Bl/6 mice on day 9 following CA04 infection. (B–E) Total numbers of AMs (B–C) and IMs (D–E) in the lung (B and D) and BAL (C and E). Data shown are representative of 2 independent experiments with 5 mice per group. Statistical analyses were performed by two-way ANOVA; * p<0.05; ** p<0.01.